← Back to Search

Behavioural Intervention

eTMS for PTSD

N/A
Recruiting
Led By Wynn Legon, PhD
Research Sponsored by Virginia Polytechnic Institute and State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 session 1 week pre treatment and 1 session 1 week post treatment

Summary

"This trial will collect data on both the body's physical responses and behavioral changes before and after using eTMS. The participants will be veterans or first responders diagnosed with PTSD. The study will be a

Who is the study for?
This trial is for veterans and first responders who have been diagnosed with PTSD. Participants must meet certain health criteria to join, but specific inclusion and exclusion details are not provided.
What is being tested?
The study tests eTMS, a personalized brain stimulation treatment, on individuals with PTSD. It's a double-blind trial meaning neither the participants nor the researchers know who gets real treatment or placebo. The effects are measured before and after treatment.
What are the potential side effects?
Specific side effects of eTMS aren't listed here, but generally TMS can cause discomfort at the stimulation site, headache, lightheadedness, or seizures in rare cases.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 session 1 week pre treatment and 1 session 1 week post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 session 1 week pre treatment and 1 session 1 week post treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adverse Events
Report of Symptoms
Secondary study objectives
EEG
OPM
PCL-5
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: eTMSExperimental Treatment1 Intervention
The active side of a TMS coil will be used to administer eTMS application.
Group II: eTMS shamPlacebo Group1 Intervention
The sham side of a TMS coil will be used to administer a sham dosage of eTMS application.

Find a Location

Who is running the clinical trial?

Virginia Polytechnic Institute and State UniversityLead Sponsor
156 Previous Clinical Trials
25,725 Total Patients Enrolled
Wave NeuroscienceIndustry Sponsor
12 Previous Clinical Trials
896 Total Patients Enrolled
Wynn Legon, PhDPrincipal InvestigatorVirginia Polytechnic Institute and State University
4 Previous Clinical Trials
445 Total Patients Enrolled
~13 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top